Insider · CIK 0001887569

Park Robert J

Reports to the SEC for 1 company · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001887569

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-12	DLBDolby Laboratories, Inc.S Sale	SVP & Chief Financial Officer	SSale	−4,504 sh	$56.62	−$255K	81,881
2026-05-12	DLBDolby Laboratories, Inc.S Sale	SVP & Chief Financial Officer	SSale	−391 sh	$57.35	−$22.4K	81,490
2025-12-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−2,285 sh	$66.62	−$152K	86,385
2025-12-15	DLBDolby Laboratories, Inc.A Award	SVP & Chief Financial Officer	AAward	+23.4K sh	—	—	89,456
2025-12-15	DLBDolby Laboratories, Inc.M Exercise/Conversion	SVP & Chief Financial Officer	MExercise/Conversion	+5,687 sh	—	—	95,143
2025-12-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−6,473 sh	$67.54	−$437K	88,670
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP & Chief Financial Officer	AAward	+11.7K sh	—	—	11,685
2025-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Financial Officer	AAward	+51.5K sh	—	—	51,460
2025-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion	SVP & Chief Financial Officer	MExercise/Conversion	−5,687 sh	—	—	0
2024-12-16	DLBDolby Laboratories, Inc.A Award	SVP & Chief Financial Officer	AAward	+18.1K sh	—	—	73,012
2024-12-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−3,725 sh	$79.18	−$295K	69,287
2024-12-16	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP & Chief Financial Officer	AAward	+9,070 sh	—	—	9,070
2024-12-16	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Financial Officer	AAward	+31.9K sh	—	—	31,890
2024-10-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−3,552 sh	$74.36	−$264K	54,871
2024-10-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−3,552 sh	$69.11	−$245K	66,085
2023-12-15	DLBDolby Laboratories, Inc.A Award	SVP & Chief Financial Officer	AAward	+15K sh	—	—	60,025
2023-12-15	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−1,887 sh	$88.60	−$167K	58,138
2023-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP & Chief Financial Officer	AAward	+7,497 sh	—	—	7,497
2023-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Financial Officer	AAward	+26.3K sh	—	—	26,283
2023-10-16	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−3,485 sh	$80.44	−$280K	44,937
2022-12-15	DLBDolby Laboratories, Inc.A Award	SVP & Chief Financial Officer	AAward	+17.6K sh	—	—	48,016
2022-12-15	DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award	SVP & Chief Financial Officer	AAward	+8,797 sh	—	—	8,797
2022-12-15	DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award	SVP & Chief Financial Officer	AAward	+31.7K sh	—	—	31,677
2022-10-17	DLBDolby Laboratories, Inc.F Tax Payment	SVP & Chief Financial Officer	FTax Payment	−3,485 sh	$64.28	−$224K	30,224
2021-10-15	DLBDolby Laboratories, Inc.A Award	SVP & Chief Financial Officer	AAward	+33.5K sh	—	—	33,523
2021-10-15	DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)A Award	SVP & Chief Financial Officer	AAward	+49.9K sh	—	—	49,886

Recent filings

Accepted (ET)
May 144
Park Robert J0001193125-26-224607
SEC(opens sec.gov)
Dec 174
Park Robert J0001193125-25-323422
SEC(opens sec.gov)
Oct 164
Park Robert J0001193125-25-241734
SEC(opens sec.gov)
Dec 184
Park Robert J0000950170-24-138161
SEC(opens sec.gov)
Oct 174
Park Robert J0000950170-24-115335
SEC(opens sec.gov)
Dec 194
Park Robert J0001209191-23-059258
SEC(opens sec.gov)
Oct 174
Park Robert J0001209191-23-052987
SEC(opens sec.gov)

Companies

Dolby Laboratories, Inc.SVP & Chief Financial OfficerDLB

Address

C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET

SAN FRANCISCO, CA, 94103